Optimising Treatment of Elderly Patients with Ovarian Cancer: Improving Their Enrolment in Clinical Trials

ISSN： 1170-229X

Source： Drugs & Aging, Vol.22, Iss.2, 2005-01, pp. : 95-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current treatment and clinical trials in ovarian cancer

By Han Liz Y Kipps Emma Kaye Stan B

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 4, 2010-04 ,pp. : 521-534

Informa Healthcare

Access to resources Recommend Favorite

Cost of cancer clinical trials in elderly patients

By Balducci Lodovicco

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 505-511

Informa Healthcare

Access to resources Recommend Favorite

Acute Myeloid Leukaemia: Optimising Treatment in Elderly Patients

By Jackson G.H. Taylor P.R.A.

Drugs & Aging, Vol. 19, Iss. 8, 2002-01 ,pp. : 571-581

Adis International

Access to resources Recommend Favorite

Applying Proteomics in Clinical Trials: Assessing the Potential and Practical Limitations in Ovarian Cancer

By Tchabo Nana E. Liel Meghan S. Kohn Elise C.

American Journal of PharmacoGenomics, Vol. 5, Iss. 3, 2005-01 ,pp. : 141-148

Adis International

Access to resources Recommend Favorite

Ethnic minorities, the elderly and women are under-represented in cancer clinical trials

Inpharma, Vol. 1, Iss. 1442, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite